Different factor H-related protein patterns in siblings with typical hemolytic uremic syndrome

Pediatric Nephrology

Volumn 26, Issue 8, 2011, Pages 1345-1347

  Benz, Marcus R ^a   Schmid, Holger ^b   Heinen, Stefan ^c,d   Lange Sperandio, Bärbel ^a   Hoefele, Julia ^a   Sitter, Thomas ^b   Zipfel, Peter F ^c,e   Weber, Lutz T ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c HANS KNÖLL INSTITUTE   (Germany)

^d MOUNT SINAI HOSPITAL   (Canada)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3D; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED PROTEIN 1; COMPLEMENT FACTOR H RELATED PROTEIN 3; CREATININE; HEMOGLOBIN; LACTATE DEHYDROGENASE; NITROGEN; UNCLASSIFIED DRUG; UREA; VEROTOXIN 2;

ACUTE KIDNEY FAILURE; ADOLESCENT; BLOODY DIARRHEA; BOY; CASE REPORT; CHILD; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COOMBS NEGATIVE HEMOLYTIC ANEMIA; CREATININE BLOOD LEVEL; DISEASE COURSE; ELECTROLYTE INTAKE; FECES ANALYSIS; FEMALE; FLUID THERAPY; FOLLOW UP; GENETIC VARIABILITY; GIRL; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; MALE; MEDICAL HISTORY; PARENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REFERENCE VALUE; SCHISTOSOMA; SCHOOL CHILD; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SIBLING; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL;

EID: 85027935388     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1885-y     Document Type: Letter

References (7)

1. Taylor CM, Machin S, Wigmore SJ, Goodship TH, Working party from the Renal Association, the British Committee for Standards in Haematology and the British Transplantation Society (2010) Clinical practice guidelines for themanagement of atypical haemolytic uraemic syndrome in the United Kingdom. Br J Haematol 148:37-47.
2. Zimmerhackl LB, Besbas N, Jungraithmayr T, van de Kar N, Karch H, Karpman D, Landau D, Loirat C, Proesmans W, Prüfer F, Rizzoni G, Taylor MC, European Study Group for Haemolytic Uraemic Syndromes and Related Disorders (2006) Epidemiology, clinical presentation, and pathophysiology of atypical recurrent hemolytic uremic syndrome. Semin Thromb Hemost 32:113-120.
3. Siegler RL, Sherbotie JR, Denkers ND, Pavia AT (2003) Clustering of post-diarrheal (Shiga toxin-mediated) haemolytic uremic syndrome in families. Clin Nephrol 60:74-79. (Pubitemid 36975180)
4. Maruvada R, Blom AM, Prasadarao NV (2008) Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells. Immunology 124:265-276. (Pubitemid 351692907)
5. Heinen S, Hartmann A, Lauer N, Wiehl U, Dahse HM, Schirmer S, Gropp K, Enghardt T, Wallich R, Hälbich S, Mihlan M, Schötzer-Schrehardt U, Zipfel PF, Skerka C (2009) Factor H related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114:2439-2447.
6. Zipfel PF, Edey M, Heinen S, Józsi M, Richter H, Misselwitz J, Hoppe B, Routledge D, Strain L, Hughes AE, Goodship JA, Licht C, Goodship THJ, Skerka C (2007) Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet 3:e41.
7. Jószi M, Licht C, Strobel S, Zipfel SLH, Richter H, Heinen S, Zipfel PF, Skerka C (2008) Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood 111:1512-1514. (Pubitemid 351213440)